메뉴 건너뛰기




Volumn 11, Issue 1, 1997, Pages 95-100

Efficacy and tolerability of a one-week triple therapy consisting of pantoprazole, clarithromycin and amoxycillin for cure of Helicobacter pylori infection in patients with duodenal ulcer

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; PANTOPRAZOLE;

EID: 0031031554     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1997.130301000.x     Document Type: Article
Times cited : (47)

References (39)
  • 2
    • 0141665944 scopus 로고    scopus 로고
    • Does treatment of Helicobacter pylori (Hp) with antibiotics alone heal duodenal ulcer (DU)?
    • Abstract
    • Lam SK, Ching CK, Lai KC, et al. Does treatment of Helicobacter pylori (Hp) with antibiotics alone heal duodenal ulcer (DU)? Gastroenterology 1996; 110: A169(Abstract).
    • (1996) Gastroenterology , vol.110
    • Lam, S.K.1    Ching, C.K.2    Lai, K.C.3
  • 3
    • 0029911619 scopus 로고    scopus 로고
    • Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: A review
    • Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 1996; 110: 1244-52.
    • (1996) Gastroenterology , vol.110 , pp. 1244-1252
    • Hopkins, R.J.1    Girardi, L.S.2    Turney, E.A.3
  • 4
    • 0027968850 scopus 로고
    • Review article: Treatments that impact favourable upon the eradication of Helicobacter pylori and ulcer recurrence
    • Tytgat GNJ. Review article: treatments that impact favourable upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994; 8: 359-68.
    • (1994) Aliment Pharmacol Ther , vol.8 , pp. 359-368
    • Tytgat, G.N.J.1
  • 5
    • 0028176847 scopus 로고
    • Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse
    • Labenz J, Börsch G. Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 1994; 55: 19-23.
    • (1994) Digestion , vol.55 , pp. 19-23
    • Labenz, J.1    Börsch, G.2
  • 6
    • 0028898537 scopus 로고
    • Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease
    • Rokkas T, Karameris A, Mavrogeorgis A, et al. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc 1995; 41: 1-4.
    • (1995) Gastrointest Endosc , vol.41 , pp. 1-4
    • Rokkas, T.1    Karameris, A.2    Mavrogeorgis, A.3
  • 7
    • 0028139162 scopus 로고
    • Quality of life and relapse of duodenal ulcer before and after eradication of Helicobacter pylori
    • Wilhelmsen I, Berstad A. Quality of life and relapse of duodenal ulcer before and after eradication of Helicobacter pylori. Scand J Gastroenterol 1994; 29: 874-9.
    • (1994) Scand J Gastroenterol , vol.29 , pp. 874-879
    • Wilhelmsen, I.1    Berstad, A.2
  • 8
    • 0028958934 scopus 로고
    • Costs of duodenal ulcer therapy with antibiotics
    • Sonnenberg A, Townsend WF. Costs of duodenal ulcer therapy with antibiotics. Arch Intern Med 1995; 155: 922-8.
    • (1995) Arch Intern Med , vol.155 , pp. 922-928
    • Sonnenberg, A.1    Townsend, W.F.2
  • 9
    • 0028766786 scopus 로고
    • Consensus development panel on Helicobacter pylori in peptic ulcer disease
    • National Institutes of Health. Consensus development panel on Helicobacter pylori in peptic ulcer disease. J Am Med Assoc 1994; 272: 65-9.
    • (1994) J Am Med Assoc , vol.272 , pp. 65-69
  • 10
    • 0030604372 scopus 로고    scopus 로고
    • Consensus statement. Medical treatment of peptic ulcer disease. Practical guidelines
    • Soll AH. Consensus statement. Medical treatment of peptic ulcer disease. Practical guidelines. J Am Med Assoc 1996; 275: 622-9.
    • (1996) J Am Med Assoc , vol.275 , pp. 622-629
    • Soll, A.H.1
  • 11
    • 0001797677 scopus 로고
    • Efficacy and tolerability of a short-term, low-dose triple therapy for eradication of Helicobacter pylori
    • Abstract
    • Bazzoli F, Zagari RM, Fossi S, Pozzato P, Roda A, Roda E. Efficacy and tolerability of a short-term, low-dose triple therapy for eradication of Helicobacter pylori. Gastroenterology 1993; 104: A140 (Abstract).
    • (1993) Gastroenterology , vol.104
    • Bazzoli, F.1    Zagari, R.M.2    Fossi, S.3    Pozzato, P.4    Roda, A.5    Roda, E.6
  • 12
    • 0029008053 scopus 로고
    • Low-dose, short term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers
    • Jaup BH, Norrby A. Low-dose, short term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers. Am J Gastroenterol 1995; 90: 943-5.
    • (1995) Am J Gastroenterol , vol.90 , pp. 943-945
    • Jaup, B.H.1    Norrby, A.2
  • 13
    • 0028944932 scopus 로고
    • One-week low dose triple therapy for cure of Helicobacter pylori infection
    • Labenz J, Stolte M, Rühl GH, et al. One-week low dose triple therapy for cure of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1995; 7: 9-11.
    • (1995) Eur J Gastroenterol Hepatol , vol.7 , pp. 9-11
    • Labenz, J.1    Stolte, M.2    Rühl, G.H.3
  • 14
    • 1842326120 scopus 로고    scopus 로고
    • Highly effective twice a day triple therapies for Helicobacter pylori infection and peptic ulcer disease - Metronidazole resistance is of minor importance
    • Abstract
    • Lerang F, Moum B, Haug JB, et al. Highly effective twice a day triple therapies for Helicobacter pylori infection and peptic ulcer disease - metronidazole resistance is of minor importance. Gastroenterology 1996; 110: A173 (Abstract).
    • (1996) Gastroenterology , vol.110
    • Lerang, F.1    Moum, B.2    Haug, J.B.3
  • 15
    • 0002123672 scopus 로고
    • The MACH 1 study: Optimal one-week treatment for H. pylori defined?
    • Abstract
    • Lind T, Veldhuyzen van Zanten SJO, Unge P, et al. The MACH 1 study: optimal one-week treatment for H. pylori defined? Gut 1995; 37 (Suppl. 1): A4 (Abstract).
    • (1995) Gut , vol.37 , Issue.1 SUPPL.
    • Lind, T.1    Veldhuyzen Van Zanten, S.J.O.2    Unge, P.3
  • 16
    • 0029091042 scopus 로고
    • Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori
    • Moayyedi P, Sahay P, Tompkins S, Axon ATR. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 1995; 7: 835-40.
    • (1995) Eur J Gastroenterol Hepatol , vol.7 , pp. 835-840
    • Moayyedi, P.1    Sahay, P.2    Tompkins, S.3    Axon, A.T.R.4
  • 18
    • 0029080377 scopus 로고
    • Rationale for the choice of antibiotics for the eradication of Helicobacter pylori
    • Mégraud F. Rationale for the choice of antibiotics for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1995; 7 (Suppl. 1): 49-54.
    • (1995) Eur J Gastroenterol Hepatol , vol.7 , Issue.1 SUPPL. , pp. 49-54
    • Mégraud, F.1
  • 19
    • 0000211308 scopus 로고    scopus 로고
    • Metronidazole resistance is high in Korea and Colombia and appears to be rapidly increasing in the U.S
    • Abstract
    • Reddy R, Osato M, Gutiérrez O, Kim JG, Graham DY. Metronidazole resistance is high in Korea and Colombia and appears to be rapidly increasing in the U.S. Gastroenterology 1996; 110: A238 (Abstract).
    • (1996) Gastroenterology , vol.110
    • Reddy, R.1    Osato, M.2    Gutiérrez, O.3    Kim, J.G.4    Graham, D.Y.5
  • 20
    • 0000701452 scopus 로고
    • Dual therapy of clarithromycin (CL) and omeprazole (OM) for treatment of patients with duodenal ulcers (DU) associated with H. pylori (HP) infection
    • Abstract
    • Hunt R, Schwartz H, Fitch D, Fedorak R, Al Kawas F, Vakil N. Dual therapy of clarithromycin (CL) and omeprazole (OM) for treatment of patients with duodenal ulcers (DU) associated with H. pylori (HP) infection. Gut 1995; 37 (Suppl. 1): A5 (Abstract).
    • (1995) Gut , vol.37 , Issue.1 SUPPL.
    • Hunt, R.1    Schwartz, H.2    Fitch, D.3    Fedorak, R.4    Al Kawas, F.5    Vakil, N.6
  • 21
    • 0028337717 scopus 로고
    • The role of acid inhibition in the treatment of Helicobacter pylori infection
    • Axon ATR. The role of acid inhibition in the treatment of Helicobacter pylori infection. Scand J Gastroenterol 1994; 29 (Suppl. 201): 16-23.
    • (1994) Scand J Gastroenterol , vol.29 , Issue.201 SUPPL. , pp. 16-23
    • Axon, A.T.R.1
  • 22
    • 0029877964 scopus 로고    scopus 로고
    • Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders
    • Fitton A, Wiseman L. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders. Drugs 1996; 51: 460-82.
    • (1996) Drugs , vol.51 , pp. 460-482
    • Fitton, A.1    Wiseman, L.2
  • 24
    • 0027220336 scopus 로고
    • Qualitative und semiquantitative invasive und nicht-invasive Diagnostik der Helicobacter pylori-Infektion der gastralen Mukosa
    • Labenz J, Stolte M, Aygen S, Hennemann O, Bertrams J, Börsch G. Qualitative und semiquantitative invasive und nicht-invasive Diagnostik der Helicobacter pylori-Infektion der gastralen Mukosa. Z Gastroenterol 1993; 31: 437-43.
    • (1993) Z Gastroenterol , vol.31 , pp. 437-443
    • Labenz, J.1    Stolte, M.2    Aygen, S.3    Hennemann, O.4    Bertrams, J.5    Börsch, G.6
  • 25
    • 0025829185 scopus 로고
    • The Sydney system. Histological division
    • Price AB. The Sydney system. Histological division. J Gastroenterol Hepatol 1991; 6: 209-22.
    • (1991) J Gastroenterol Hepatol , vol.6 , pp. 209-222
    • Price, A.B.1
  • 26
    • 0007493406 scopus 로고
    • Validity of a new biopsy urease test and simplified 13C-urea breath test for diagnosis of Helicobacter pylori infection and estimation of the severity of gastritis
    • Abstract
    • Labenz J, Aygen S, Hennemann O, et al. Validity of a new biopsy urease test and simplified 13C-urea breath test for diagnosis of Helicobacter pylori infection and estimation of the severity of gastritis. Gut 1995; 37(Suppl. 1): A54 (Abstract).
    • (1995) Gut , vol.37 , Issue.1 SUPPL.
    • Labenz, J.1    Aygen, S.2    Hennemann, O.3
  • 28
    • 0029869590 scopus 로고    scopus 로고
    • One-week triple therapy with omeprazole, amoxycillin and either clarithromycin or metronidazole for cure of Helicobacter pylori infection
    • Labenz J, Stolte M, Peitz U, Tillenburg B, Becker T, Börsch G. One-week triple therapy with omeprazole, amoxycillin and either clarithromycin or metronidazole for cure of Helicobacter pylori infection. Aliment Pharmacol Ther 1996; 10: 207-10.
    • (1996) Aliment Pharmacol Ther , vol.10 , pp. 207-210
    • Labenz, J.1    Stolte, M.2    Peitz, U.3    Tillenburg, B.4    Becker, T.5    Börsch, G.6
  • 29
    • 0028884690 scopus 로고
    • Addition of metronidazole to omeprazole/amoxycillin dual therapy increases the rate of Helicobacter pylori eradication: A double-blind, randomized trial
    • Bell GD, Bate CM, Axon ATR, et al. Addition of metronidazole to omeprazole/amoxycillin dual therapy increases the rate of Helicobacter pylori eradication: a double-blind, randomized trial. Aliment Pharmacol Ther 1995; 9: 513-20.
    • (1995) Aliment Pharmacol Ther , vol.9 , pp. 513-520
    • Bell, G.D.1    Bate, C.M.2    Axon, A.T.R.3
  • 30
    • 0008325246 scopus 로고    scopus 로고
    • One week low-dose triple therapy for eradication of H. pylori: A large multicentre randomised trial
    • Abstract
    • Misiewicz JJ, Harris AW, Bardhan KD, Levi S, Langworthy H. One week low-dose triple therapy for eradication of H. pylori: a large multicentre randomised trial. Gastroenterology 1996; 110: A198 (Abstract).
    • (1996) Gastroenterology , vol.110
    • Misiewicz, J.J.1    Harris, A.W.2    Bardhan, K.D.3    Levi, S.4    Langworthy, H.5
  • 31
    • 0011489777 scopus 로고
    • Omeprazole + amoxycillin + clarithromycin therapy for H. pylori eradication
    • Abstract
    • Burette A, Glupczynski Y, Deprez C, Ramdani B, Omeprazole + amoxycillin + clarithromycin therapy for H. pylori eradication. Gut 1995; 37 (Suppl. 1): A89 (Abstract).
    • (1995) Gut , vol.37 , Issue.1 SUPPL.
    • Burette, A.1    Glupczynski, Y.2    Deprez, C.3    Ramdani, B.4
  • 32
    • 0000972239 scopus 로고
    • Dual therapy with high dose of omeprazole vs. triple therapy using omeprazole in combination with two antibiotics: Results of a randomized controlled trial among 100 patients
    • Cayla R, Zerbib F, De Mascarel A, Mégraud F, Lamouliatte H. Dual therapy with high dose of omeprazole vs. triple therapy using omeprazole in combination with two antibiotics: results of a randomized controlled trial among 100 patients. Am J Gastroenterol 1994; 89: 1366.
    • (1994) Am J Gastroenterol , vol.89 , pp. 1366
    • Cayla, R.1    Zerbib, F.2    De Mascarel, A.3    Mégraud, F.4    Lamouliatte, H.5
  • 33
    • 0000946979 scopus 로고
    • Eradication of Helicobacter pylori using clarithromycin, omeprazole and amoxycillin for one week
    • Abstract
    • Tonge KA, Goddard AF, Logan RPH, et al. Eradication of Helicobacter pylori using clarithromycin, omeprazole and amoxycillin for one week. Gastroenterology 1995; 106: A242 (Abstract).
    • (1995) Gastroenterology , vol.106
    • Tonge, K.A.1    Goddard, A.F.2    Logan, R.P.H.3
  • 34
    • 0028607147 scopus 로고
    • Additive effect of clarithromycin with 14-hydroxy clarithromycin, erythromycin, amoxycillin, metronidazole or omeprazole against Helicobacter pylori
    • Cederbrant G, Kahlmeter G, Schálen C, Kamme C, Additive effect of clarithromycin with 14-hydroxy clarithromycin, erythromycin, amoxycillin, metronidazole or omeprazole against Helicobacter pylori. J Antimicrob Chemother 1994; 34: 1025-9.
    • (1994) J Antimicrob Chemother , vol.34 , pp. 1025-1029
    • Cederbrant, G.1    Kahlmeter, G.2    Schálen, C.3    Kamme, C.4
  • 35
    • 0029013440 scopus 로고
    • Effect of acidic environment on the susceptibility of Helicobacter pylori to spectomycin and other antimicrobial agents
    • Debets-Ossenkopp YJ, Namavar F, MacLaren DM. Effect of acidic environment on the susceptibility of Helicobacter pylori to spectomycin and other antimicrobial agents. Eur J Clin Microbiol Infect Dis 1995; 14: 353-5.
    • (1995) Eur J Clin Microbiol Infect Dis , vol.14 , pp. 353-355
    • Debets-Ossenkopp, Y.J.1    Namavar, F.2    MacLaren, D.M.3
  • 36
    • 0001100728 scopus 로고    scopus 로고
    • Randomized comparison of 7, 10, and 14 days of omeprazole, amoxycillin. and clarithromycin for treatment of H. pylori
    • Abstract
    • Laine L, Estrada R, Trujillo M, Fukanaga K, NeilG. Randomized comparison of 7, 10, and 14 days of omeprazole, amoxycillin. and clarithromycin for treatment of H. pylori. Gastroenterology 1996; 110: A168(Abstract).
    • (1996) Gastroenterology , vol.110
    • Laine, L.1    Estrada, R.2    Trujillo, M.3    Fukanaga, K.4    Neil, G.5
  • 37
    • 0002890162 scopus 로고    scopus 로고
    • Pantoprazole, clarithromycin and metronidazole vs. pantoprazole and clarithromycin for cure of H. pylori infection in duodenal ulcer patients
    • Abstract
    • Adamek RJ, Bethke T. Pantoprazole, clarithromycin and metronidazole vs. pantoprazole and clarithromycin for cure of H. pylori infection in duodenal ulcer patients. Gastroenterology 1996; 110: A48 (Abstract).
    • (1996) Gastroenterology , vol.110
    • Adamek, R.J.1    Bethke, T.2
  • 38
    • 0003212683 scopus 로고    scopus 로고
    • Pantoprazole (Panto)-based 10-day triple therapy is effective for H. pylori eradication
    • Abstract
    • Bardhan KD, Slater DN, Morton D, et al. Pantoprazole (Panto)-based 10-day triple therapy is effective for H. pylori eradication. Gastroenterology 1996; 110: A57 (Abstract).
    • (1996) Gastroenterology , vol.110
    • Bardhan, K.D.1    Slater, D.N.2    Morton, D.3
  • 39
    • 0029043543 scopus 로고
    • Short-term triple therapy with pantoprazole, clarithromycin and metronidazole for eradication of Helicobacter pylori
    • Labenz J, Peitz U, Tillenburg B, Becker T, Börsch G, Stolte M. Short-term triple therapy with pantoprazole, clarithromycin and metronidazole for eradication of Helicobacter pylori. Leber Magen Darm 1995; 25: 122-7.
    • (1995) Leber Magen Darm , vol.25 , pp. 122-127
    • Labenz, J.1    Peitz, U.2    Tillenburg, B.3    Becker, T.4    Börsch, G.5    Stolte, M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.